QuidelOrtho director granted 1,183 common shares
QuidelOrtho Corp director Kenneth J. Widder reported routine equity compensation activity involving restricted stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
QuidelOrtho Corp director Kenneth J. Widder reported routine equity compensation activity involving restricted stock units. On June 6, 2026, he acquired 273 and 910 shares of common stock at $0.00 per share through grants/awards.
These shares came from the release and conversion of previously reported restricted stock units into common stock, with 273 and 910 units exercised at a $0.00 conversion price. Footnotes explain that the restricted stock unit release had been deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors and occurred according to his elected deferral schedule.
Insider Trade Summary
1,183 shares exercised/converted
Exercise
4 txns
Insider
WIDDER KENNETH J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (Converted) | 910 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units (Premium) | 273 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 910 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 273 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units (Converted) — 0 contracts (Direct);
Restricted Stock Units (Premium) — 0 contracts (Direct);
Common Stock — 45,073 shares (Direct)
Footnotes (3)
- F1. Reflects release of restricted stock units that were previously reported on a Form 4.
- F2. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
- F3. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Key Figures
Share grant 1: 273 shares
Share grant 2: 910 shares
RSUs exercised total: 1,183 units
+1 more
4 metrics
Share grant 1
273 shares
Common stock grant/award on June 6, 2026 at $0.00
Share grant 2
910 shares
Common stock grant/award on June 6, 2026 at $0.00
RSUs exercised total
1,183 units
Restricted stock units converted to common stock
Exercise price
$0.00 per unit
Conversion of restricted stock units into common stock
Key Terms
restricted stock units, restricted stock unit, deferred compensation program, non-employee directors
4 terms
restricted stock units financial
"Reflects release of restricted stock units that were previously reported on a Form 4."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
restricted stock unit financial
"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
deferred compensation program financial
"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors"
non-employee directors financial
"QuidelOrtho's deferred compensation program applicable to participating non-employee directors"
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did QuidelOrtho (QDEL) director Kenneth Widder report in this Form 4?
Kenneth J. Widder reported the acquisition of common shares tied to restricted stock units. On June 6, 2026, previously granted units were released and converted into QuidelOrtho common stock as part of his non-employee director compensation.
Were Kenneth Widder’s QuidelOrtho (QDEL) transactions open-market purchases or sales?
The transactions were not open-market trades. They reflect grants and the exercise or conversion of restricted stock units at a zero-dollar price, consistent with equity compensation rather than discretionary buying or selling in the market.
What are the restricted stock units referenced in QuidelOrtho (QDEL) director Widder’s filing?
Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. In this filing, units previously reported on an earlier Form 4 were released and converted into common shares according to the applicable plan terms.
How does QuidelOrtho’s deferred compensation program affect this Form 4 for QDEL?
The filing notes that restricted stock unit releases were deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors. The actual conversion into common shares occurred according to Kenneth Widder’s previously elected deferral schedule.
Does this QuidelOrtho (QDEL) Form 4 indicate a change in Kenneth Widder’s trading views?
The Form 4 reflects routine compensation-related equity releases and conversions, not discretionary market trades. It records the scheduled delivery of shares from prior restricted stock unit awards under the company’s non-employee director compensation and deferral programs.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates